List of Excipients in API doxylamine succinate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxylamine succinate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | ALCOHOL | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | AMMONIA | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | BUTYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxylamine succinate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE |
| L Perrigo Company | doxylamine succinate | 0113-0441 | CELLULOSE, MICROCRYSTALLINE |
| L Perrigo Company | doxylamine succinate | 0113-0441 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for doxylamine succinate
Excipient focus: ALCOHOL
doxylamine succinate drug variants containing ALCOHOL
doxylamine succinate drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
doxylamine succinate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chattem Inc | doxylamine succinate | 41167-0063 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
doxylamine succinate drug variants containing AMMONIA
doxylamine succinate drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
doxylamine succinate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Rite Aid Corporation | doxylamine succinate | 11822-9386 |
| Better Living Brands LLC | doxylamine succinate | 21130-386 |
| Better Living Brands LLC | doxylamine succinate | 21130-986 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
doxylamine succinate drug variants containing BUTYL ALCOHOL
doxylamine succinate drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
doxylamine succinate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Better Living Brands LLC | doxylamine succinate | 21130-386 |
| SUPERVALU INC | doxylamine succinate | 41163-386 |
| Wal-Mart Stores Inc | doxylamine succinate | 49035-863 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
doxylamine succinate drug variants containing CARNAUBA WAX
doxylamine succinate drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxylamine succinate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doxylamine succinate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 27
doxylamine succinate drug variants containing D&C RED NO. 27
doxylamine succinate drug variants not containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxylamine succinate drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rite Aid Corporation | doxylamine succinate | 11822-0386 |
| Better Living Brands LLC | doxylamine succinate | 21130-386 |
| H E B | doxylamine succinate | 37808-986 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
doxylamine succinate drug variants containing DIMETHICONE
doxylamine succinate drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
doxylamine succinate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| 7-Eleven | doxylamine succinate | 10202-441 |
| Rite Aid Corporation | doxylamine succinate | 11822-9386 |
| Better Living Brands LLC | doxylamine succinate | 21130-986 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
doxylamine succinate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Rite Aid Corporation | doxylamine succinate | 11822-9386 |
| Better Living Brands LLC | doxylamine succinate | 21130-986 |
| Belmora LLC | doxylamine succinate | 27854-375 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
doxylamine succinate drug variants containing FD&C BLUE NO. 2
doxylamine succinate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
doxylamine succinate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
doxylamine succinate drug variants containing FERROSOFERRIC OXIDE
doxylamine succinate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doxylamine succinate drug variants containing HYPROMELLOSE
doxylamine succinate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
doxylamine succinate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
doxylamine succinate drug variants containing ISOPROPYL ALCOHOL
doxylamine succinate drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
doxylamine succinate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM TRISILICATE
doxylamine succinate drug variants containing MAGNESIUM TRISILICATE
doxylamine succinate drug variants not containing MAGNESIUM TRISILICATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
doxylamine succinate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
doxylamine succinate drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Par Pharmaceutical Inc | doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | 49884-186 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
doxylamine succinate drug variants containing POLYETHYLENE GLYCOL
doxylamine succinate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
doxylamine succinate drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
doxylamine succinate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Bryant Ranch Prepack | doxylamine succinate and pyridoxine hydrochloride | 63629-8358 |
| Analog Pharma | doxylamine succinate and pyridoxine hydrochloride | 70505-100 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
doxylamine succinate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Bryant Ranch Prepack | doxylamine succinate and pyridoxine hydrochloride | 63629-8358 |
| Analog Pharma | doxylamine succinate and pyridoxine hydrochloride | 70505-100 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
doxylamine succinate drug variants containing POLYSORBATE 80
doxylamine succinate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
doxylamine succinate drug variants containing PROPYLENE GLYCOL
doxylamine succinate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
doxylamine succinate drug variants containing SHELLAC
doxylamine succinate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doxylamine succinate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
doxylamine succinate drug variants containing SODIUM BICARBONATE
doxylamine succinate drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
doxylamine succinate drug variants containing SODIUM LAURYL SULFATE
doxylamine succinate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
doxylamine succinate drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| The Procter & Gamble Manufacturing Company | doxylamine succinate | 69423-902 |
| YYBA CORP | doxylamine succinate | 73581-205 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
doxylamine succinate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Rite Aid Corporation | doxylamine succinate | 11822-0386 |
| Rite Aid Corporation | doxylamine succinate | 11822-9386 |
| Better Living Brands LLC | doxylamine succinate | 21130-386 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
doxylamine succinate drug variants containing TALC
doxylamine succinate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doxylamine succinate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
doxylamine succinate drug variants containing TRIETHYL CITRATE
doxylamine succinate drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | doxylamine succinate | 0113-0441 |
| L Perrigo Company | doxylamine succinate | 0113-6044 |
| L Perrigo Company | doxylamine succinate | 0113-7441 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
